The Kantaro antibody test kit is now available in the US and in 29 European countries. To obtain the test for your organization, please fill out our intake form at: https://t.co/ViJVpDkp1d
"It is important for people with immune system disorders [...] to work with their doctors and to understand their response to their COVID-19 vaccines due to the varied antibody responses to the vaccines we see in this study," -- Ania Wajnberg, MD
https://t.co/7o882QuIZp
COVID-SeroKlir, Kantaro's semi-quantitative antibody test kit, has received authorization from Health Canada under the #COVID19 Interim Order. The test is available immediately. For more, see: https://t.co/0WoKmVEjpt
“'We believe that COVID-19 survivors should only get one dose of mRNA vaccine [Pfizer and Moderna], which would speed the rate of immunization by allowing others to get these additional doses,' research authors, including eminent Mount Sinai virologist Florian Krammer, wrote..."
We're proud to announce that our COVID-SeroKlir semi-quantitative antibody test kit for #COVID19 has been named to @FastCompany's World Changing Ideas in the Pandemic Response category. Read more here: https://t.co/1NOTXn44TJ
#FCWorldChangingIdeas
"We'll look at the durability of the response, namely measure the antibodies. [...] You can project when it's going to be so low you might have more danger of breakthrough infection." Dr. Anthony Fauci on the need for antibody testing:
https://t.co/7wGwb13Ddz …
"SeroKlir is unique in that it is instrument-agnostic and can be used on any brand of technology. This is a considerable benefit to any region or country that wants to adopt antibody testing in the fight against COVID-19," Read more:
https://t.co/ymHJaFiHyy
We’re Number 1 in the Joint Venture list of
@FastCompany’s Most Innovative Companies for 2021. Read more here: https://t.co/JhcKg5mjTD
#FCMostInnovative
We’re pleased and honored to be named to @FastCompany’s World’s Most Innovative Companies for 2021 in recognition of our work. Read more here: https://t.co/0jp1gTJwyg
#FCMostInnovative
We're pleased to be the test of choice in an important study focused on COVID-19 immune response in Spanish healthcare workers, led by @Atrys_Health and @Vithas. Read more:
https://t.co/X9NNOLrHUm
“This agreement represents another critical step forward in bringing the Kantaro quantitative antibody tests to doctors, patients and researchers in regions affected by COVID-19,�� said Sara Barrington, Kantaro’s chief commercial officer. https://t.co/rrNS3IdIJT
Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
Learn more: https://t.co/S2aVoGkfe2
"Quantitative IgG antibody testing can provide important support for determining public health strategies...and verifying the effectiveness of vaccines as they become available." --Julian Baines, CEO of @EKFdiagnostics#COVID19#antibody
https://t.co/upNBLUPAez
In 30 min, tune in to @SirisusXM channel 110 to hear Dr. Erik Lium, Kantaro board chair, and Dr. @florian_krammer speak with @marinakurian on @NYUdoc’s show about antibody testing’s key role in fighting #COVID19. Listen here: https://t.co/cNvP7sG2Fe
Tune in tomorrow at 8:30 am ET to hear Kantaro leadership speak about antibody testing’s key role in fighting #COVID19 on @NYUdocs’s show on
@SiriusXM channel 110